A Phase I Clinical Trial of Topotecan Given Every 2 Weeks in Patients with Refractory Solid Tumors
Kakolyris, S., Kouroussis, Ch., Souglakos, J., Mavroudis, D., Agelaki, S., Kalbakis, K., Androulakis, N., Vardakis, N., Vamvakas, L., Georgoulias, V.Volume:
61
Language:
english
Journal:
Oncology
DOI:
10.1159/000055332
Date:
November, 2001
File:
PDF, 149 KB
english, 2001